Research
NAD⁺ and nicotinamide riboside: what the lab shows - and what everyday life does not yet
Cow milk contains a substance that went largely unnoticed for a long time: nicotinamide riboside, NR for short. Around 40% of the NAD⁺ precursors in milk are present in this form.1 Today NR is one of the best-known substances in ageing research.
The reason is a molecule called NAD⁺. It declines with age, and NR can raise it in the blood. The more important question is: what does a higher NAD⁺ level actually change in humans?
This article sorts the human studies on NR and the meta-analyses on related precursors. And it shows which amounts the EU permits.
What is NAD⁺, and what does the cell need it for?
NAD⁺ (nicotinamide adenine dinucleotide) is a coenzyme, a helper molecule for enzymes. It transfers electrons and is therefore central to energy metabolism. At the end of it, the cell gains ATP, its energy currency.2,3
In addition, 3 groups of enzymes need NAD⁺. These are the sirtuins, the PARP enzymes of DNA repair and the surface enzyme CD38. Through them NAD⁺ influences metabolic pathways, DNA repair, cellular ageing and immune cells.2 Sirtuins also play a part in the article on resveratrol.
Does NAD⁺ decline with age?
In several model organisms, NAD⁺ levels in tissues and cells decline with age. According to a 2021 review, this also applies to humans.2 A study in Cell Reports notes that human data on this are still sparse.4
In animal studies, restoring NAD⁺ in old or diseased animals can promote health and extend lifespan.5 This gave rise to the idea of raising NAD⁺ in humans with precursors.
What works in old mice is still only a hypothesis in humans.
What is nicotinamide riboside, and where is it found?
Nicotinamide riboside is a precursor of NAD⁺.6 In the body it provides nicotinamide, a form of niacin (vitamin B3).7 Related precursors are nicotinic acid, nicotinamide and nicotinamide mononucleotide (NMN).8,9
Foods contain NR in small amounts. Cow milk contains around 12 micromoles of NAD⁺ precursors per litre, 40% of them as NR.1 In food supplements it is present as nicotinamide riboside chloride, a synthetically produced form.7
Does nicotinamide riboside raise NAD⁺ levels?
Yes, this is the best-established finding. In a placebo-controlled study over 8 weeks, overweight but otherwise healthy adults took 100, 300 or 1,000 mg NR a day. NAD⁺ in whole blood rose by 22%, 51% and 142% within 2 weeks. The rise lasted until the end of the study.10
More NR, more NAD⁺ in the blood
Rise in whole-blood NAD⁺ after 2 weeks, by daily amount
A crossover study in healthy middle-aged and older adults ran for 2 × 6 weeks. Here too, NR was well tolerated and stimulated NAD⁺ metabolism.11

In 12 older men who took 1 g NR a day for 21 days, NAD⁺ metabolites rose even in skeletal muscle.4 So NR reaches the tissue. Whether that changes anything about health is a different question.
What do studies show on muscle, blood pressure and inflammation?
Here the evidence becomes thin. In the muscle study, NR did not change mitochondrial performance. The activity of genes for energy metabolism and mitochondria in muscle even decreased. Inflammatory messengers in the blood went down.4

A meta-analysis on muscle mass and muscle function in people over 60 found no difference from placebo for NMN. For NR there were only single studies, with mixed results. In people with poor blood flow to the legs, walking distance was longer; in mild cognitive impairment, 2 function tests were worse. The authors see no basis for using NR or NMN to preserve muscle.12
On blood pressure, the 2018 crossover study called for further research.11 A randomised pilot study from 2025 tested this in 54 adults aged 55 and over with raised blood pressure. 1,000 mg NR a day plus walking exercise did not lower blood pressure over 6 weeks more than placebo plus exercise.13
Nicotinamide riboside in humans: what was measured
NR compared with placebo, per study or meta-analysis
NAD⁺ · Conze 2019, Martens 2018
Muscle · Elhassan 2019 · 12 men, 1 g, 21 days
Muscle · Prokopidis 2025 · over 60 years
Blood pressure · Lin 2025 · 54 people, 6 weeks
A review of 25 published human studies on NR reached a sober verdict in 2023. It found few clinically relevant effects and a tendency in the literature to exaggerate findings. The authors consider a possible role in inflammatory states conceivable.6
A higher NAD⁺ value in the blood is a lab value, not yet a benefit.
What do meta-analyses show for NAD⁺ precursors overall?
Many reviews do not study NR but the related precursor NMN. A meta-analysis of 12 studies with 513 participants found a clear rise in NAD⁺ in the blood. Most metabolic values, however, did not differ from the control group.9
A second meta-analysis covered 8 studies with 342 adults and 250-2,000 mg NMN a day. It found no difference in fasting blood glucose, insulin, long-term blood glucose (HbA1c) and blood lipids.14
A broader analysis of 45 studies with 9,256 participants covered all NAD⁺ precursors, including nicotinic acid. Blood glucose rose slightly, by 2.17 mg/dl, as did HbA1c. The inflammation marker CRP fell by 0.93 mg/l. Nicotinic acid raised blood glucose more than nicotinamide.8
Related precursors: NAD⁺ rises, metabolic values barely change
Precursor compared with the control group, per meta-analysis
NMN · Zhang 2025 · 12 studies, 513 participants
NMN · Chen 2024 · 8 studies, 250-2,000 mg
All NAD⁺ precursors · Sohouli 2024 · 45 studies
These results cannot be transferred one to one to NR. But they show a pattern: the NAD⁺ value rises reliably, metabolic values mostly do not.
How well tolerated is nicotinamide riboside?
In the 8-week dose study there were no reports of skin flushing. Adverse events were not more frequent with NR than with placebo, not even at 1,000 mg. LDL cholesterol did not rise.10
A systematic review of NAD⁺, NADH and precursors found mainly mild complaints: muscle pain, fatigue, sleep disturbance and headaches. None of the events was a serious health risk.3
Long-term data are lacking. The NMN studies in the meta-analysis ran for 14 days to 12 weeks, the NR dose study for 8 weeks.10,14 EFSA also points to experimental data suggesting that amounts far above requirements could cause harm through several pathways. It considers that a re-evaluation of the upper limit for nicotinamide may be warranted.15
Is nicotinamide riboside authorised in the EU, and how much is allowed?
Nicotinamide riboside chloride is a novel food in the EU, authorised in 2020 for food supplements. The basis was a 2019 EFSA opinion. According to it, up to 300 mg a day is safe for healthy adults, excluding pregnant and breastfeeding women. For them, EFSA considered up to 230 mg a day safe.7,16
The EU list sets the maximum amounts accordingly. For adults it is 300 mg a day, excluding pregnant and breastfeeding women. For pregnant and breastfeeding women it is 230 mg a day. The label names the substance as nicotinamide riboside chloride.16
Study amounts and the EU maximum amounts
Milligrams per day
Several human studies used 1,000 mg a day, well above this maximum.4,10,13 Authorisation as a novel food governs safety, amount and labelling, not the effect. There is no authorised health claim for nicotinamide riboside itself.17 How to recognise tested claims is explained in the article on EU health claims.
What does it all add up to?
Nicotinamide riboside is neither a miracle substance nor an empty promise. It is a well-studied NAD⁺ precursor with one clear lab finding and few clinical findings.
3 points are solid. NR raises NAD⁺ in the blood depending on the amount. It was well tolerated in the studies. For muscle, blood pressure and metabolism, studies so far show no established difference.6,10,12,13
Another coenzyme of energy metabolism is covered in the article on coenzyme Q10.
Key points
- NR is an NAD⁺ precursor and provides nicotinamide, a form of vitamin B3.6,7
- NAD⁺ is central to energy metabolism, DNA repair and cell signalling. It declines with age; in humans this has been little studied.2,4
- 100-1,000 mg NR a day raised NAD⁺ in the blood by 22-142%.10
- For muscle and blood pressure, studies so far found no established benefit.12,13
- EU maximum: 300 mg a day for adults, 230 mg for pregnant and breastfeeding women. There is no authorised health claim.16,17
Sources
- Trammell SA, Yu L, Redpath P, Migaud ME, Brenner C. Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk. Journal of Nutrition, 2016.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 2021.
- Gindri IM, Ferrari G, Pinto LPS, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. American Journal of Physiology Endocrinology and Metabolism, 2024.
- Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports, 2019.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metabolism, 2018.
- Damgaard MV, Treebak JT. What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances, 2023.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC. EFSA Journal, 2019.
- Sohouli MH, Tavakoli S, Reis MG, Hekmatdoost A, Guimarães NS. Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD+ precursor supplementation: a systematic review and meta-regression analysis. Nutrition & Metabolism, 2024.
- Zhang J, Poon ET, Wong SH. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Critical Reviews in Food Science and Nutrition, 2025.
- Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports, 2019.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 2018.
- Prokopidis K, Moriarty F, Bahat G, et al. The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle, 2025.
- Lin Y, Zeidan RS, Lapierre-Nguyen S, et al. Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial. GeroScience, 2025.
- Chen F, Zhou D, Kong AP, et al. Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Current Diabetes Reports, 2024.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Extension of use of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal, 2021.
- Commission Implementing Regulation (EU) 2022/1160 of 5 July 2022 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use and the specifications of the novel food nicotinamide riboside chloride. Official Journal of the European Union, 2022.
- European Commission. Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Consolidated version of 20 August 2025.
ATLAS All-in-One - 35 ingredients, 4 capsules, once a day.
